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Introduction
Future developments in pharmaceutical research and
regulatory requirements such as the European REACH
program require high numbers of animal experiments.
As a result of ethical concerns, cell culture tests with
human cell lines or primary cells are considered as an
alternative. However, current testing protocols using 2D
cell cultures in Petri dishes are not equivalent to animal
trials. 3D tissue cultures may overcome fundamental
obstacles in the development of new therapeutic agents.
Many new candidates of therapeutic agents are intended
as agonists or antagonists of specific receptors on
human cells. For these substances, organ-like test sys-
tems based on human cells are mandatory. In some
cases, new pharmaceuticals lead to unexpected adverse
reactions even after successful animal trials. It is
a s s u m e dt h a t3 Dt e s ts y s t e m sb a s e do nh u m a nc e l l s
might help to overcome these problems.
Materials and methods
Human hepatoma HepG2 cell line was cultivated in
monolayer culture and on two 3D carrier systems
macroporous ceramic carrier Sponceram (Zellwerk, Ger-
many) and Fibracel composed of polyester non-woven
fiber on a polypropylene scaffold (New Brunswick Scien-
tific, USA). 3D-carrier cultivation was performed in 24-
well-plates, in a multi-well flow-chamber bioreactor or a
fixed bed (Fig. 1) [1]. Cells were seeded at cell densities
of 1*10
5/ml. Medium was DMEM/Ham´s F-12 mixture
supplemented with 10% FBS. Growth of cultures was
determined using DNA measurement with H33528 after
digesting the cells with Papain.An average DNA content
of 14.8 pg DNA per cell was previously obtained using
defined cell concentrations. Functional assays were car-
ried out according to the method described in [2] using
7-ethoxyresorufin as a substrate. Induction of EROD
activitiy was done using 3-methyl-cholanthrene or Keto-
conazole. Cellular viability was monitored using Resa-
zurin and live/dead staining (AO/PI).
Cell growth on carrier systems
On Sponceram, cells spreaded initially but formed dense
clusters after extended cultivation. On FibraCel, cells
formed small aggregates after seeding. Later they grew
within the whole carrier structure. In the flow chamber
3.83 · 10
5 ±6 . 0 4·1 0
4 cells per carrier were reached
w i t h i nt w oc o m p a r e dt o1 . 4 5·1 0
6 ±3 . 6 8·1 0
6 in 24
well plates. For the fixed bed an average of approx. 1.35
·1 0
6 cells per carrier were obtained.
Liver specific EROD assay
The cultivation of Hep G2 cells in the two reactor sys-
tems was carried out for 7 days and for 14 days prior to
induction of EROD activity.. Measurement of EROD
activity found to be linear for at least for 1h (sampling
every 15 min). Activities were similar to static cultures
in the flow chamber [approx. 1.7 fmol Resorufin/
(cell*h)]. Lower activities were detected in the fixed bed
bioreactor after 14d [approx. 0.5 fmol Resorufin/(cell*h)]
compared to 7d [approx. 0.15 fmol Resorufin/(cell*h)],
possibly as a result of the formation of large cell
clusters. * Correspondence: poertner@tuhh.de
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In this study it was shown that 3D dynamic culture sys-
tems can be used to carry out functional assays such as
the EROD assay with a human liver cell line. HepG2
cells could be cultivated for a longer time in dynamic
3D culture and showed a better viability compared to
static monolayer cultivation.
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Figure 1 Cultivation systems for 3D-culture of HepG2-cells (A) Multi-wellf l o w - c h a m b e rb i o r e a c t o r( m e d o r e x )( B )1 0m Lf i x e db e dr e a c t o r
(medorex) [1]
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